Pfizer records high earnings despite problems with antismoking drug
NEW YORK Pfizer released its second earnings report and despite the loss of more than a third of its sales for its anti-smoking drug Chantix due to safety concerns, the company reported that earnings more than doubled on higher sales of its prescription drugs, according to published reports.
The company earned $2.78 billion in the second quarter, compared to $1.27 billion a year earlier, when Pfizer took large charges for restructuring and merger-related costs.
Company revenue rose 9 percent to $12.13 billion, but would have increased only 2 percent if not for the weak dollar, which boosts the value of overseas sales when converted back into U.S. currency.
Pfizer’s U.S. sales fell 2 percent, hurt by decreasing demand for Chantix, a new medicine that Pfizer has been counting on to drive earnings growth in coming years, and loss of patent protection on allergy drug Zyrtec and cancer drug Camptosar.
Expert panel recommends lifestyle changes for pre-diabetics
NEW YORK A panel of experts from the American Association of Clinical Endocrinologists has recommended two approaches for treating patients with pre-diabetes.
In a statement released Wednesday morning, the panel recommended significant management of lifestyle to prevent the onset of diabetes. It also recommended preventing cardiovascular complications from developing.
Pre-diabetes is a condition in which patients have high levels of glucose or low tolerance to sugar, but don’t have high enough levels to be diabetic. The condition puts patients at high risk of developing Type 2 diabetes. Pre-diabetes affects 56 million Americans, according to the Centers for Disease Control and Prevention.
SF pharmacy tobacco ban up for vote
SAN FRANCISCO A San Francisco Board of Supervisors committee sent a proposed amendment to the city’s health code that would ban tobacco sales at pharmacies to the full board Thursday for a vote.
After the City Operations and Neighborhood Services Committee heard testimony from city government officials, industry representatives, anti-tobacco activists and pharmacy workers, Supervisor Carmen Chu, who chairs the committee, allowed it to go forward.
Proponents of the amendment say that pharmacies send a mixed message by selling cigarettes and medicines. Opponents call the proposed ban unfair because it exempts supermarkets and big-box stores that operate pharmacies.
The Board of Supervisors, the legislative body for the consolidated city and county of San Francisco, will vote on the amendment Tuesday.